Nanobiotix (NASDAQ:NBTX – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, September 28th. Parties interested in listening to the company's conference call can do so using this link.
Nanobiotix Price Performance
Shares of NBTX opened at $3.95 on Monday. Nanobiotix has a 12-month low of $2.32 and a 12-month high of $13.37. The firm has a 50-day moving average price of $3.98 and a 200 day moving average price of $4.94.
Get
Nanobiotix alerts:
About Nanobiotix
(Get Rating)
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
See Also
- Get a free copy of the StockNews.com research report on Nanobiotix (NBTX)
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
Nanobiotix (NASDAQ:NBTX – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, September 28th. Parties interested in listening to the company's conference call can do so using this link.
Nanobiotix(纳斯达克代码：NBTX-GET Rating)计划在9月28日周三股市收盘后发布季度收益数据。有兴趣收听该公司电话会议的各方可以使用此链接进行收听。
Nanobiotix Price Performance
Shares of NBTX opened at $3.95 on Monday. Nanobiotix has a 12-month low of $2.32 and a 12-month high of $13.37. The firm has a 50-day moving average price of $3.98 and a 200 day moving average price of $4.94.
周一，NBTX的股价开盘报3.95美元。Nanobiotix的12个月低点为2.32美元，12个月高位为13.37美元。该公司的50日移动均线价格为3.98美元，200日移动均线价格为4.94美元。
Get
Nanobiotix
alerts:
About Nanobiotix
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Nanobiotix SA是一种临床阶段的生物技术，专注于开发治疗癌症的候选产品。它的主要候选产品是NBTXR3，这是一种由晶态氧化钨纳米颗粒组成的无菌水悬浮液，用于治疗软组织肉瘤、头颈癌、肝癌、前列腺癌、胰腺癌、食道癌、直肠癌和非小细胞肺癌。
See Also
- Get a free copy of the StockNews.com research report on Nanobiotix (NBTX)
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- 免费获取StockNews.com关于Nanobiotix的研究报告(NBTX)
- 卡特彼勒能否在下跌的市场中走得更高？
- Dave&Buster‘s能免受高通胀和低支出的影响吗？
- 这三只表现最好的中型股应该出现在你的观察名单上吗？
- 华尔街对Datadog的热情会带来巨大的收益吗？
- MarketBeat：回顾一周9/19-9/23
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
接受Nanobiotix日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Nanobiotix和相关公司的最新新闻和分析师评级的每日简要摘要。
